Capricor Therapeutics (CAPR) Assets Average (2011 - 2026)

Capricor Therapeutics' Assets Average history runs 16 years deep, the most recent figure standing at $341.1 million for Q1 2026.

• In Q1 2026, Assets Average rose 110.41% year-over-year to $341.1 million; the TTM figure through Mar 2026 stood at $341.1 million (up 110.41% YoY), while the FY2025 annual figure was $263.2 million, up 129.67% from the prior year.
• Assets Average was $341.1 million for Q1 2026 at Capricor Therapeutics, up from $241.2 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $341.1 million in Q1 2026 to a low of $41.6 million in Q3 2023.
• Historically, Assets Average has averaged $101.6 million across 5 years, with a median of $56.0 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Assets Average declined 25.74% in 2023, then jumped 227.55% in 2025.
• A 5-year view of Assets Average shows it stood at $52.0 million in 2022, then decreased by 7.82% to $47.9 million in 2023, then surged by 174.73% to $131.7 million in 2024, then surged by 83.12% to $241.2 million in 2025, then surged by 41.43% to $341.1 million in 2026.
• The last three Assets Average figures came in at $341.1 million (Q1 2026), $241.2 million (Q4 2025), and $130.0 million (Q3 2025), per Business Quant data.